<SEC-DOCUMENT>0001213900-23-037335.txt : 20230508
<SEC-HEADER>0001213900-23-037335.hdr.sgml : 20230508
<ACCEPTANCE-DATETIME>20230508160526
ACCESSION NUMBER:		0001213900-23-037335
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20230503
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230508
DATE AS OF CHANGE:		20230508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mawson Infrastructure Group Inc.
		CENTRAL INDEX KEY:			0001218683
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		IRS NUMBER:				880445167
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40849
		FILM NUMBER:		23897703

	BUSINESS ADDRESS:	
		STREET 1:		201 CLARK STREET
		CITY:			SHARON
		STATE:			PA
		ZIP:			16146
		BUSINESS PHONE:		61 02 8624 6130

	MAIL ADDRESS:	
		STREET 1:		201 CLARK STREET
		CITY:			SHARON
		STATE:			PA
		ZIP:			16146

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Wize Pharma, Inc.
		DATE OF NAME CHANGE:	20171120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OphthaliX, Inc.
		DATE OF NAME CHANGE:	20120207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DENALI CONCRETE MANAGEMENT INC
		DATE OF NAME CHANGE:	20030213
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea178118-8k_mawson.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:MIGI="http://mawsoninc.com/20230503">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_MIGI_mawsoninc.com_20230503 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20230503_20230503 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001218683 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:EntityCentralIndexKey">0001218683</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="migi-20230503.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-05-03to2023-05-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001218683</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-03</xbrli:startDate>
        <xbrli:endDate>2023-05-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_901_edei--DocumentType_c20230503__20230503_zumjaTQP8eEj"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span style="text-decoration: underline"><span id="xdx_908_edei--DocumentPeriodEndDate_c20230503__20230503_zX7ovjdMRAX9"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May 3, 2023</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_90A_edei--EntityRegistrantName_c20230503__20230503_zYi2TsUtryBa"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:EntityRegistrantName">Mawson Infrastructure Group Inc.</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20230503__20230503_zuThtzEkc67g"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></p></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_edei--EntityFileNumber_c20230503__20230503_zwxs8G4qe8K7"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:EntityFileNumber">001-40849</ix:nonNumeric></span> </td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20230503__20230503_z2bT9YjOgTyh"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:EntityTaxIdentificationNumber">88-0445167</ix:nonNumeric></span> </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt">(State or other jurisdiction <br />
of incorporation)</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(Commission File Number)</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(IRS Employer <br />
Identification No.)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><span id="xdx_90D_edei--EntityAddressAddressLine1_c20230503__20230503_zIxPzh14DhYe"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:EntityAddressAddressLine1">201 Clark Street</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressCityOrTown_c20230503__20230503_zP5JggmwSAuj"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:EntityAddressCityOrTown">Sharon</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressStateOrProvince_c20230503__20230503_zeWYXKN0E0j2"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:EntityAddressStateOrProvince">PA</ix:nonNumeric></span> <span id="xdx_90B_edei--EntityAddressCountry_c20230503__20230503_zBIoEERHFLjk"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">USA</ix:nonNumeric></span></td>
  <td style="text-align: center; padding-bottom: 1.5pt; width: 2%">&#160;</td>
  <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><span id="xdx_90A_edei--EntityAddressPostalZipCode_c20230503__20230503_zMt5ENUNiVN2"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:EntityAddressPostalZipCode">16146</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center">(Address of principal executive offices)</td>
  <td style="text-align: center">&#160;</td>
  <td style="text-align: center">(Zip Code)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code <span id="xdx_904_edei--CityAreaCode_c20230503__20230503_zHC6YeSq8qc3"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:CityAreaCode">+61 02</ix:nonNumeric></span> <span id="xdx_90D_edei--LocalPhoneNumber_c20230503__20230503_zoZugaU2lllf"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:LocalPhoneNumber">8624 6130</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 55%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--WrittenCommunications_c20230503__20230503_zyJDcPym38Hl"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--SolicitingMaterial_c20230503__20230503_zKjfD5vBUc11"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--PreCommencementTenderOffer_c20230503__20230503_z2PKusLVtoC5"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20230503__20230503_zBQbrC7eQNsk"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Title of Each Class</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Name of Each Exchange on Which Registered</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_908_edei--Security12bTitle_c20230503__20230503_z4DzzenH6WCg"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:Security12bTitle">Common Stock, $0.001 par value&#9;</ix:nonNumeric></span> </span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90A_edei--TradingSymbol_c20230503__20230503_zcGNIQC7z6w5"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" name="dei:TradingSymbol">MIGI</ix:nonNumeric></span></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">The <span id="xdx_901_edei--SecurityExchangeName_c20230503__20230503_zOuHXLWx28q4"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20230503__20230503_z37rcC65tAX9"><ix:nonNumeric contextRef="From2023-05-03to2023-05-03" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>Item 1.01</b> <b>Entry into a Material Definitive Agreement.</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 3, 2023, Mawson Infrastructure Group Inc.
(&#8220;we,&#8221; &#8220;us,&#8221; the &#8220;Company&#8221; or &#8220;Mawson&#8221;) entered into a Securities Purchase Agreement (the
&#8220;Purchase Agreement&#8221;) with institutional investors providing for the issuance and sale by the Company of an aggregate of 2,083,336
shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, par value $0.001 per share (&#8220;Common Stock&#8221;) (or pre-funded
warrants (the &#8220;Pre-Funded Warrants&#8221;) in lieu thereof) in a registered direct offering (the &#8220;Registered Offering&#8221;),
and (iii) a concurrent private placement (the &#8220;Private Placement&#8221; and, together with the Registered Offering, the &#8220;Offering&#8221;)
of warrants (the &#8220;Common Warrants&#8221;) to purchase up to 2,604,170 shares of Common Stock (the &#8220;Common Warrant Shares&#8221;
and together with the Shares, the Pre-Funded Warrants, the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants and
the Common Warrants, the &#8220;Securities&#8221;). The offering price per Share and associated Common Warrant was $2.40 and the offering
price per Pre-Funded Warrant and associated Common Warrant was $2.399, which represents the per share offering price per Share less the
$0.001 per share exercise price for each Pre-Funded Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">The Pre-Funded
Warrants are immediately exercisable, have an exercise price of $0.001 and may be exercised at any time until all of the Pre-Funded Warrants
are exercised in full. The Common Warrants have an exercise price of $</span>3.23 <span style="background-color: white">per share of Common
Stock, are exercisable 6 months after issuance and will expire five</span> and one-half years following issuance<span style="background-color: white">.
The exercise price of the Prefunded Warrants and Common Warrants is subject to adjustment for stock splits, reverse splits, and similar
capital transactions as described in the Prefunded Warrants and Common Warrants, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">As a condition
to entering into the Purchase Agreement, the Company amended the warrants previously issued to one of the investors in this Offering under
the Securities Purchase Agreement dated July 17, 2022, and further described in the Company&#8217;s Current Report on Form 8-K filed on
July 19, 2022, to purchase up to an aggregate of 1,666,667 shares of Common Stock for an exercise price of $6.06 per share (the &#8220;Existing
Warrants&#8221;), effective upon the closing of the Offering, such that the amended Existing Warrants have a reduced exercise price of
$3.23 per share, will be exercisable six months following the closing of the Offering, and will expire five and one-half years following
the closing of the Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The Offering
closed on </span>May 8, 2023<span style="background-color: white">. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">The
gross proceeds to the Company from the Offering were approximately $5 million, before deducting the placement agent&#8217;s fees and other
offering expenses payable by the Company. The Company intends to use the net proceeds from the Offering to continue to build out its digital
infrastructure, for potential strategic transactions and also for general corporate purposes, including working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">The
Purchase Agreement contains customary representations and warranties of the Company, termination rights of the parties, and certain indemnification
obligations of the Company and ongoing covenants of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase Agreement,
the Company has agreed that (i) it will not conduct any issuances of Common Stock for a period of ninety (90) days and that (ii) it will
not enter into a variable rate transaction, in each case for a period of one (1) year following the closing of the offering, subject to
certain exceptions as set forth in the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Registered Offering was made pursuant to a
prospectus supplement dated May 3, 2023, and a base prospectus which is part of a <span style="background-color: white">Registration Statement
on</span> Form S-3 (File No. 333-264062) that was filed with the U.S. Securities and Exchange Commission on April 1, 2022, as amended,
and was declared effective on April 11, 2022 (the Registration Statement&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">In connection
with the Offering, the Company entered into an engagement letter with H.C. Wainwright &amp; Co., LLC (the &#8220;Placement Agent&#8221;)
dated May 1, 2023, pursuant to which the Placement Agent agreed to serve as the exclusive placement agent for the issuance and sale of
securities of the Company in this Offering. As compensation to the Placement Agent, the Company will pay the Placement Agent a cash fee
of 7.0% of the aggregate gross proceeds raised in the Offering, up to $85,000 for fees and expenses of legal counsel and other out-of-pocket
expenses in connection with the Offering and reimbursement of certain expenses and legal fees. The Company will also issue to designees
of the Placement Agent warrants to purchase up to </span>116,667 <span style="background-color: white">shares of Common Stock (the &#8220;Placement
Agent Warrants&#8221;). The Placement Agent Warrants have substantially the same terms as the Common Warrants, except that the Placement
Agent Warrants have an exercise price equal to $</span>3.00 <span style="background-color: white">per share and have a term of five years
from the commencement of sales in the Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Current Report does not constitute an offer
to sell or the solicitation of an offer to buy any security nor any sale of these securities in any state in which such offer, solicitation
or sale would be unlawful prior to registration or qualification under the securities laws of any such state.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The forms of the Purchase Agreement, the Pre-Funded
Warrant, the Common Warrant and Placement Agent Warrant are filed as exhibits to this Current Report on Form 8-K and are incorporated
by reference herein. The description of each such document is qualified in its entirety by reference to the full text of such document
as incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Attached hereto as Exhibit 5.1, and incorporated
by reference to the Prospectus Supplement, is the opinion of Sheppard Mullin Richter &amp; Hampton LLP relating to the legality of the
securities issued in the Registered Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item. 3.02. Unregistered Sales of Equity Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information contained above in Item 1.01 related
to the Private Placement and the issuance of the Placement Agent Warrants is hereby incorporated by reference into this Item 3.02. The
Common Warrants, the Placement Agent Warrants and the shares of Common Stock issuable upon exercise of the Common Warrants and the Placement
Agent Warrants have not been registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and are instead
being offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act and/or Regulation D promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>Item 8.01</b> <b>Other Events.</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 4, 2023, the Company issued a press release
announcing the pricing of the Offering. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and
is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective May 4, 2023, the Company filed a prospectus
supplement to amend, supplement and supersede certain information contained in the prospectus supplement dated May 27, 2022, and its accompanying
prospectus dated April 11, 2022 (collectively, the &#8220;May 2022 Prospectus&#8221;), relating to the offer and sale of Common Stock
through H.C. Wainwright &amp; Co., LLC (&#8220;Wainwright&#8221;), as sales agent, in &#8220;at the market offerings&#8221; as defined
in Rule 415 promulgated under the Securities Act of 1933, as amended, pursuant to the At the Market Offering Agreement with Wainwright
dated as of May 27, 2022 (the &#8220;ATM Agreement&#8221;). The prospectus supplement reduced the amount of shares of Common Stock the
Company may offer and sell under the ATM Agreement to an aggregate offering price of up to $9,000,000 from time to time through Wainwright.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under
the May 2022 Prospectus, the Company initially registered up to $100,000,000 of our Common Stock for offer and sale pursuant to the ATM
Agreement. However, on March 23, 2023, the date we filed our Annual Report on Form 10-K for the year ended December 31, 2022, our Registration
Statement became subject to the offering limits set forth in General Instruction I.B.6 of Form S-3. As of May 3, 2023, the aggregate market
value of our outstanding Common Stock held by non-affiliates was approximately $45,720,757.33, which we calculated based on 14,371,373
shares of outstanding Common Stock as of May 3, 2023, of which 12,735,587 shares were held by non-affiliates, and a price per share of
$3.59 which was the closing price of our Common Stock on March 23, 2023. During the 12 calendar months prior to and including the date
of this prospectus, we have offered $745,551.00 of securities pursuant to General Instruction I.B.6 of Form S-3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>Item 9.01.</b></span> <span style="font-size: 10pt"><b>Financial Statements and Exhibits. </b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">In
reviewing the Purchase Agreement included as Exhibit 10.1 to this Current Report on Form 8-K, please remember it is included to provide
you with information regarding its terms and is not intended to provide any other factual or disclosure information about us or the other
party to such agreement. These agreements contain representations and warranties by each of the parties thereto. These representations
and warranties have been made solely for the benefit of the other party to the agreement and:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">should not in all instances be treated as categorical statements of fact, but rather as a way of allocating
the risk to one of the parties if those statements prove to be inaccurate;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                            been qualified by disclosures that were made to the other party in connection with the negotiation
                                            of the agreement, which disclosures are not necessarily reflected in the agreement;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
                                            apply standards of materiality in a way that is different from what may be viewed as material
                                            to you or other investors; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">were
                                            made only as of the date of the agreement or such other date or dates as may be specified
                                            in the agreement and are subject to more recent developments. Accordingly, these representations
                                            and warranties may not describe the actual state of affairs as of the date they were made
                                            or at any other time.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: justify"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 2%"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; width: 89%; text-align: justify"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td><a href="ea178118ex4-1_mawson.htm"><span style="font-size: 10pt">Form of Common Warrant</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">4.2</span></td>
    <td>&#160;</td>
    <td><a href="ea178118ex4-2_mawson.htm"><span style="font-size: 10pt">Form of Pre-Funded Warrant</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">4.3</span></td>
    <td>&#160;</td>
    <td><a href="ea178118ex4-3_mawson.htm"><span style="font-size: 10pt">Form of Placement Agent Warrant</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">4.4</span></td>
    <td>&#160;</td>
    <td><a href="ea178118ex4-4_mawson.htm"><span style="font-size: 10pt">Form of Warrant Amendment Agreement dated May 3, 2023</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">5.1</span></td>
    <td>&#160;</td>
    <td><a href="ea178118ex5-1_mawson.htm"><span style="font-size: 10pt">Opinion of Sheppard Mullin Richter &amp; Hampton LLP</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td><a href="ea178118ex10-1_mawson.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement </span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">23.1</span></td>
    <td>&#160;</td>
    <td><a href="ea178118ex5-1_mawson.htm"><span style="font-size: 10pt">Consent of Sheppard Mullin Richter &amp; Hampton LLP (included as part of Exhibit 5.1)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td><a href="ea178118ex99-1_mawson.htm"><span style="font-size: 10pt">Press Release, dated May 4, 2023</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company cautions that statements in this report
that are not a description of historical fact are forward-looking statements within the meaning of the Private Securities Litigation Reform
Act of 1995. Forward-looking statements may be identified by the use of words referencing future events or circumstances such as &#8220;expect,&#8221;
&#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; and &#8220;will,&#8221; among others. Because
such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking
statements. These forward-looking statements are based upon the Company&#8217;s current expectations and involve assumptions that may
never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated
in such forward-looking statements as a result of various risks and uncertainties. More detailed information about the risks and uncertainties
affecting the Company is contained under the heading &#8220;Risk Factors&#8221; included in the Company&#8217;s Annual Report on Form
10-K filed with the SEC on March 23, 2023, and in other filings that the Company has made and may make with the SEC in the future. One
should not place undue reliance on these forward-looking statements, which speak only as of the date on which they were made. Because
such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking
statements. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after
the date on which they were made, except as may be required by law.</p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">SIGNATURES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>Mawson Infrastructure Group Inc.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 36%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Date: May 8, 2023</span></td>
    <td><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt">/s/ James Manning</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">James Manning</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">4</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2OmpVrPAyqYgsQiK6XXKMJd2R2bWfR+ot25RoGBiGc75zhBiJNa10jQznRZHDEZu2Vg6hwAoZzQW9I9tsU/C3wKu2jpVx/fsDM/IMeiYZh3Plhd561xbLFGQykbNJFIOcpnECh50IvnpGptIlGqdVDcqUcGBqWaNT/BoSjupJhppXX3VCtppMCuFYDvIbIhlGsKe7ehDfLOR5JoJRP4FYM3Xtt6azjhpY1tj4Ljug/w0+Hq1JVA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea178118ex4-1_mawson.htm
<DESCRIPTION>FORM OF COMMON WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">NEITHER THIS SECURITY NOR THE
SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MAWSON INFRASTRUCTURE GROUP, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: ______</FONT></TD>
    <TD STYLE="width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise Date: November __, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date: May __, 2023</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS COMMON STOCK PURCHASE WARRANT
(the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
November __, 2023 (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on November __, 2028
(the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Mawson Infrastructure Group, Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated May __, 2023, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)   <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares
specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless
exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice
of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of
Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in
an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number
of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one
(1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant
Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)   <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$____</B>, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)   <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part,
at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(A)</TD>
    <TD STYLE="text-align: center; width: 0.25in">=</TD><TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</TD>
</TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD STYLE="text-align: left">(B)</TD>
    <TD STYLE="text-align: center">=</TD><TD>the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD STYLE="text-align: left">(X)</TD>
    <TD STYLE="text-align: center">=</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares shall tack back to the holding period of this Warrant. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.   <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the resale of the Warrant Shares by the Holder or (B) the Warrant
Shares are eligible for resale by the Holder pursuant to Rule 144 and is being exercised via cashless exercise, and otherwise by physical
delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) ) the number
of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise and (iii) none (1)
Trading Day after delivery of the aggregate Exercise Price to the Company (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of
(i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant
Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading
Day (increasing to $20 per Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading Day after such
Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a
transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein,
&ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.   <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.   <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv.   <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v.   <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi.   <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii.   <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> e) <U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)   <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)   [RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)   <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)   <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)   <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its Subsidiaries, taken as
a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one
or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or
more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in
Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the
Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable
as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s control,
including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this
Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders
of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental
Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes
Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable
Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for
a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the
Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on
Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of
the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater
of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the public
announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if
earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section 3(e) and (D) a remaining option time equal
to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date
and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or
such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation
of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant
and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and
substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction
and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced
by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of
shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable
upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this
Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant
and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor
Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company,
may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the
obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company
and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)   <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)   <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.   <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.   <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)   <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)   <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)   <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)   <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)   <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)   <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)   <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)   <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)   <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)   <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)   <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)   <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)   <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)   <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)   <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)   <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)   <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)   <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)   <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I><BR STYLE="clear: both">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MAWSON INFRASTRUCTURE GROUP, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: </FONT><B>MAWSON
INFRASTRUCTURE GROUP, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)   The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)   Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[&nbsp;&nbsp; ] in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[&nbsp;&nbsp; ] if permitted,
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)   Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4)   <U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"> <B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Please Print)
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 43%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea178118ex4-2_mawson.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.25in"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.25in"><B>EXHIBIT A-2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PREFUNDED COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>MAWSON INFRASTRUCTURE GROUP, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 45%">Warrant Shares: ______</TD>
  <TD STYLE="text-align: right; width: 45%">Initial Exercise Date:
May ___, 2023</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PREFUNDED COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until this Warrant is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;)
but not thereafter, to subscribe for and purchase from Mawson Infrastructure Group, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price
of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.&nbsp;<U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated May ___, 2023, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>.&nbsp;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares
specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless
exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice
of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of
Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in
an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number
of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one
(1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant
Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The
Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.001, subject
to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Cashless
Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(A)</TD>
    <TD STYLE="width: 0.15in">=</TD><TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable
                                                                                Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is
                                                                                not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of
                                                                                &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on
                                                                                such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the
                                                                                applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
                                                                                (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice
                                                                                of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter
                                                                                (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a)
                                                                                hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day
                                                                                and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading
                                                                                hours&rdquo; on such Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(B)</TD>
    <TD STYLE="width: 0.15in">=</TD><TD STYLE="text-align: justify"> the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(X)</TD>
    <TD STYLE="width: 0.15in">=</TD><TD STYLE="text-align: justify"> the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&nbsp;The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) ) the number of Trading Days comprising
the Standard Settlement Period after the delivery to the Company of the Notice of Exercise and (iii) none (1) Trading Day after delivery
of the aggregate Exercise Price to the Company (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the
Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with
respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of
the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days
and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company
fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the
Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such
exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to
$20 per Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery
Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is
a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement
Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading
Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing,
with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which
may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares subject
to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share
Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received by such Warrant Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv.&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v.&nbsp;<U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi.&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">e)</TD><TD STYLE="text-align: justify"><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant,
and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that
after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section
2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be [4.99%] [9.99%] of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of
Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>.&nbsp;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;[RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its Subsidiaries, taken as
a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one
or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or
more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in
Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the
Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable
as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section
3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which
is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the
shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this
Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of
capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the
value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities,
jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor
Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with
the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>.&nbsp;<U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this
Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>.&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&nbsp;<U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>MAWSON INFRASTRUCTURE GROUP, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To:&nbsp;</FONT><B>MAWSON
INFRASTRUCTURE GROUP, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)&nbsp;The
undersigned hereby elects to purchase _____ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)&nbsp;Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[&nbsp;&nbsp;]
in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[&nbsp;&nbsp;]
if permitted, the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in
subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless
exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)&nbsp;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify">Name:</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><U STYLE="text-decoration: none"> ______________________________________</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><U> </U><U STYLE="text-decoration: none"> ______________________________________</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Phone Number:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><U STYLE="text-decoration: none"> ______________________________________</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Email Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><U STYLE="text-decoration: none"> ______________________________________</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Dated: _______________ __, ______</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Signature:_______________________<U> </U></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Address:________________________<U> </U></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ea178118ex4-3_mawson.htm
<DESCRIPTION>FORM OF PLACEMENT AGENT WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><B>Exhibit 4.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">NEITHER THIS SECURITY NOR THE
SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MAWSON INFRASTRUCTURE GROUP, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: 116,667</FONT></TD>
    <TD STYLE="text-align: left; width: 50%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise Date: November 8, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date: May 8, 2023</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PLACEMENT AGENT COMMON
STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, H.C. Wainwright &amp; Co., LLC or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after November 8, 2023 (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New
York City time) on May 3, 2028 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Mawson
Infrastructure Group, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 116,667 shares (as subject to adjustment
hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant
shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement,
by and between the Company and H.C. Wainwright &amp; Co., LLC, dated as of May 1, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated May 3, 2023, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares
specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless
exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice
of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of
Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in
an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number
of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one
(1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant
Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $3.00, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part,
at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A) </FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">= </FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B) </FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">= </FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Exercise Price of this Warrant, as adjusted hereunder;
and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 8pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X) </FONT></TD>
    <TD STYLE="padding-bottom: 8pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">= </FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 8pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares shall tack back to the holding period of this Warrant. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the resale of the Warrant Shares by the Holder or (B) the Warrant
Shares are eligible for resale by the Holder pursuant to Rule 144 and is being exercised via cashless exercise, and otherwise by physical
delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) ) the number
of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise and (iii) none (1)
Trading Day after delivery of the aggregate Exercise Price to the Company (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of
(i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant
Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading
Day (increasing to $20 per Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading Day after such
Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a
transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein,
&ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> e) <U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) [RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise, other
than cash (including, without limitation, any distribution of stock or other securities, property or options by way of a dividend, spin
off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the
beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its Subsidiaries, taken as
a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one
or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or
more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in
Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the
Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable
as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s control,
including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this
Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders
of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental
Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes
Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable
Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for
a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the
Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on
Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of
the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater
of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the public
announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if
earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section 3(e) and (D) a remaining option time equal
to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date
and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or
such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation
of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant
and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and
substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction
and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced
by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of
shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable
upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this
Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant
and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor
Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company,
may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the
obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company
and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 1in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 1in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 1in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered to
the address of the Holder in the Warrant Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I><BR STYLE="clear: both">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company has caused this
Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MAWSON INFRASTRUCTURE GROUP, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 31%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: </FONT><B>MAWSON
INFRASTRUCTURE GROUP, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"> &#9744; in
lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; if
permitted, the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise
procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) <U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"> <B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify">Name:</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><U STYLE="text-decoration: none"> ______________________________________</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><U> </U><U STYLE="text-decoration: none"> ______________________________________</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Phone Number:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><U STYLE="text-decoration: none"> ______________________________________</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Email Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><U STYLE="text-decoration: none"> ______________________________________</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Dated: _______________ __, ______</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Signature:_______________________<U> </U></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Address:________________________<U> </U></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>5
<FILENAME>ea178118ex4-4_mawson.htm
<DESCRIPTION>FORM OF WARRANT AMENDMENT AGREEMENT DATED MAY 3, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.4</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 10.5pt">May 3, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holder of Common Stock Purchase Warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re:&nbsp;<U>Reduction of Exercise Price and Extension of Term of Common
Stock Purchase Warrants</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made to
the offering on Form S-3 (File No. 333-264062) on or about the date hereof (the &ldquo;<U>Offering</U>&rdquo;) by Mawson Infrastructure
Group, Inc. (the &ldquo;<U>Company</U>&rdquo;) of its common stock, par value $0.001 per share (&ldquo;<U>Common Stock</U>&rdquo;), and/or
other securities of the Company (collectively, the &ldquo;<U>Securities</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter confirms that,
in consideration for the Holder&rsquo;s participation in the Offering and purchase of Securities in the Offering (the &ldquo;<U>Purchase
Commitment</U>&rdquo;), the Company hereby amends, effective as of the closing of the Offering, the Holder&rsquo;s existing warrants to
purchase up to 1,666,667 shares of common stock at an exercise price of $6.06 per share issued on July 20, 2022 (the &ldquo;<U>Existing
Warrants</U>&rdquo;) by (i) reducing the Exercise Price (as defined therein) of the Existing Warrants to $3.23 per share, (ii) amending
the Existing Warrants so that they will not be exercisable commencing on the date hereof and until November 8, 2023, and (iii) amending
the expiration date of the Existing Warrants to five and one-half (5.5) years following the date of issuance (the &ldquo;<U>Warrant Amendment</U>&rdquo;).
The Warrant Amendment shall be effective upon the closing the Offering and the satisfaction of the other terms and conditions referenced
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Warrant Amendment is subject
to the consummation of the Offering and the Holder&rsquo;s satisfaction of the Purchase Commitment. In the event that either (i) the Offering
is not consummated, or (ii) the Holder does not satisfy the Purchase Commitment, the Warrant Amendment shall be null and void and the
provisions of the Existing Warrants in effect prior to the date hereof shall remain in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as expressly set forth
herein, the terms and provisions of the Existing Warrants shall remain in full force and effect after the execution of this letter and
shall not be in any way changed, modified or superseded except by the terms set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From and after the effectiveness
of the Warrant Amendment, the Company agrees to promptly deliver to the Holder, upon request, amended Existing Warrants that reflect the
Warrant Amendments in exchange for the surrender for cancellation of the Holder&rsquo;s Existing Warrants to be amended as provided herein.
For any registered Existing Warrants, the Company shall file a prospectus supplement to the applicable registration statement in connection
with the amendments hereunder by the closing of the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.2in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.2in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS WHEREOF, the parties hereto have caused this agreement to
be duly executed by their respective authorized signatories as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">MAWSON INFRASTRUCTURE GROUP, Inc.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Manning</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Holder: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signature of Authorized Signatory of Holder: __________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Authorized Signatory: ____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><I>[Signature
Page to Warrant Amendment Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>6
<FILENAME>ea178118ex5-1_mawson.htm
<DESCRIPTION>OPINION OF SHEPPARD MULLIN RICHTER & HAMPTON LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ex5-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><BR>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 8, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>VIA ELECTRONIC MAIL</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mawson Infrastructure Group Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">201 Clark Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sharon, PA 16146</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as special counsel to Mawson Infrastructure
Group Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), in connection with the preparation and filing with the Securities
and Exchange Commission (the &ldquo;<B><I>Commission</I></B>&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;<B><I>Securities
Act</I></B>&rdquo;), of a registration statement on Form S-3 (File No. 333-264062) (the &ldquo;<B><I>Registration Statement</I></B>&rdquo;),
including the prospectus which forms a part of the Registration Statement (the &ldquo;<B><I>Base Prospectus</I></B>&rdquo;), and the prospectus
supplement dated May 3, 2023, filed with the Commission pursuant to Rule 424(b) under the Securities Act (the &ldquo;<B><I>Prospectus
Supplement</I></B>&rdquo; and, together with the Base Prospectus, the &ldquo;<B><I>Prospectus</I></B>&rdquo;), relating to the proposed
issuance and sale by the Company of (i)(a) 1,836,668 shares (&ldquo;<B><I>Shares</I></B>&rdquo;) of the common stock of the Company, par
value $0.001 per share (the &ldquo;<B><I>Common Stock</I></B>&rdquo;), (b) pre-funded warrants to purchase up to 246,668 shares of Common
Stock (the &ldquo;<B><I>Pre-Funded Warrants</I></B>&rdquo;) and (ii) the shares of Common Stock issuable upon exercise of the Pre-Funded
Warrants (the &ldquo;<B><I>Pre-Funded Warrant Shares</I></B>&rdquo;). The Shares, the Pre-Funded Warrants and the Pre-Funded Warrants
Shares are collectively referred to herein as the &ldquo;<B><I>Securities</I></B>&rdquo;). The Securities will be issued pursuant to a
Securities Purchase Agreement, dated May 3, 2023, between the Company and the investor signatory thereto (the &ldquo;<B><I>Securities
Purchase Agreement</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 47.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This opinion is
being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein
as to any matter pertaining to the contents of the Registration Statement or the Prospectus, other than as expressly stated herein with
respect to the issue of the Securities</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the issuance
of this opinion letter, we have examined originals or copies, certified or otherwise identified to our satisfaction, of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">a. the Registration Statement,
all exhibits thereto and the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">b.&nbsp;the Certificate of
Incorporation of the Company, as presently in effect (the &ldquo;<B><I>Charter</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">c. the Company&rsquo;s Bylaws
of the Company, as presently in effect (the &ldquo;<B><I>Bylaws</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">d. the Securities Purchase
Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">e. certain resolutions adopted
by the Board of Directors of the Company relating to the issuance of the Securities.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have also examined originals or copies, certified
or otherwise identified to our satisfaction, of such records of the Company and such agreements, certificates and receipts of public officials,
certificates of officers or other representatives of the Company and others, and such other documents as we have deemed necessary or appropriate
as a basis for the opinions stated below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In our examination, we have assumed the genuineness
of all signatures, including endorsements, the legal capacity and competency of all natural persons, the authenticity of all documents
submitted to us as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic, certified
or photostatic copies, and the authenticity of the originals of such copies. As to any facts relevant to the opinions stated herein that
we did not independently establish or verify, we have relied upon statements and representations of officers and other representatives
of the Company and others and of public officials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is understood that this opinion is to be used
only in connection with the offer and sale of the securities being registered while the Registration Statement is effective under the
Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon the foregoing and subject to the qualifications
and assumptions stated herein, we are of the opinion that (i) the Shares have been duly authorized and, when issued and delivered by the
Company against due payment therefor in accordance with the terms set forth in the Securities Purchase Agreement, will be validly issued,
fully paid and non-assessable;&nbsp;(ii) &nbsp;provided that the&nbsp;Pre-Funded&nbsp;Warrants have been duly executed and delivered by
the Company and duly delivered to the purchaser thereof against payment therefor, the&nbsp;Pre-Funded&nbsp;Warrants, when issued and sold
pursuant to the Securities Purchase Agreement as described in the Registration Statement, will be a valid and legally binding obligation
of the Company, enforceable against the Company in accordance with their terms, except as enforcement thereof may be limited by bankruptcy,
insolvency, reorganization, moratorium or other similar laws relating to or affecting creditors&rsquo; rights generally and by general
equitable principles (regardless of whether such enforceability is considered in a proceeding at law or in equity) and implied covenants
of good faith and fair dealing; and (iii) 246,668 shares of Common Stock to be issued pursuant to the Pre-Funded Warrants, when issued
upon exercise of such Pre-Funded Warrants in accordance with its terms, will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In rendering the foregoing opinion, we have assumed
that (i)&nbsp;the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL and
(ii)&nbsp;upon the issue of any of the shares of Common Stock, the total number of shares of Common Stock issued and outstanding will
not exceed the total number of shares of Common Stock that the Company is then authorized to issue under its Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The opinion which we render herein is limited
to those matters governed by the General Corporation Law of the State of Delaware (the &ldquo;DGCL&rdquo;), the State of New York and
we express no opinion with respect to any other laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the filing of this opinion
with the Commission as an exhibit to the Company&rsquo;s Current Report on Form 8-K being filed on the date hereof and incorporated by
reference into the Registration Statement.. We also hereby consent to the reference to our firm under the heading &ldquo;Legal Matters&rdquo;
in the Registration Statement. In giving this consent, we do not thereby admit that we are within the category of persons whose consent
is required under Section&nbsp;7 of the Securities Act or the General Rules and Regulations under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion letter is rendered as of the date first written above
and we disclaim any obligation to advise you of facts, circumstances, events or developments which hereafter may be brought to our attention
and which may alter, affect or modify the opinion expressed herein. Our opinion is expressly limited to the matters set forth above and
we render no opinion, whether by implication or otherwise, as to any other matters relating to the Company, the Securities or any other
agreements or transactions that may be related thereto or contemplated thereby. We are expressing no opinion as to any obligations that
parties other than the Company may have under or in respect of the securities issued pursuant to the Securities Purchase Agreement, or
as to the effect that their performance of such obligations may have upon any of the matters referred to above. No opinion may be implied
or inferred beyond the opinion expressly stated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Sheppard, Mullin, Richter &amp; Hampton&nbsp;LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SHEPPARD, MULLIN, RICHTER &amp; HAMPTON&nbsp;<FONT STYLE="text-transform: uppercase">LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>7
<FILENAME>ea178118ex10-1_mawson.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-decoration: none; font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><B>SECURITIES
PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of May 3, 2023, between Mawson Infrastructure Group, Inc., a Delaware corporation (the
&ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns,
a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to (i) an effective registration statement under the Securities Act (as defined
below) as to the Shares and Prefunded Warrants and (ii) an exemption from the registration requirements of Section 5 of the Securities
Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder as to the Common Warrants, the Company desires to issue and sell
to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more
fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE I.</B><BR>
DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2<SUP>nd</SUP>)
Trading Day following the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with
Section 2.2(a) hereof, which Common Warrants shall be exercisable six (6) months following the date of issuance and have a term of exercise
equal to five and one-half (5.5) years after the date of issuance, in the form of <U>Exhibit A-1</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Sheppard Mullin Richter &amp; Hampton LLP, with offices located at 12275 El Camino Real, Suite 100, San Diego,
California 92130-4092.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof,
unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>EGS</U>&rdquo;
means Ellenoff Grossman &amp; Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105-0302.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock, restricted stock, restricted stock units or options to employees,
officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee
members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for
services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or
other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this
Agreement, provided that (other than with respect to the Warrant Amendment (as defined below)) such securities have not been amended since
the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price
of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities, (c) warrants
to the Placement Agent in connection with the transactions pursuant to this Agreement and any securities upon the exercise of warrants
to the Placement Agent, (d) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested
directors of the Company, provided that such securities are issued (i) as &ldquo;restricted securities&rdquo; (as defined in Rule 144)
and carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition
period in Section 4.12(a) herein or (ii) pursuant to a registration statement on Form S-4, and provided that any such issuance shall only
be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of
an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to
the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising
capital or to an entity whose primary business is investing in securities, (e) Common Stock purchase warrants to purchase, in the aggregate,
up to 1,500,000 shares of Common Stock, which warrants shall not be exercisable until six months after issuance, have an expiration no
longer than the fifth anniversary of the date of issuance, an effective exercise price per share not less than $4.00 per share (subject
to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions), and which shall
otherwise have terms no less favorable to the Company than those provided for in the Common Warrants and (f) securities issued pursuant
to an amendment to certain existing warrants held by certain Purchasers (the &ldquo;<U>Warrant Amendment</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or similar restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $2.40, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement, provided that the purchase price per Prefunded
Warrant shall be the Per Share Purchase Price minus $0.001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means H.C. Wainwright &amp; Co., LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prefunded
Warrant</U>&rdquo; means, collectively, the Prefunded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Prefunded Warrants shall be exercisable immediately and shall expire when exercised in full, in the
form of <U>Exhibit A-2</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prefunded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Prefunded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such
as a deposition), whether commenced or threatened, before or by any court, arbitrator, governmental or administrative agency or regulatory
authority (federal, state, county, local or foreign).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the Commission
and delivered by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission file No. 333-264062 which registers the sale of the Shares,
the Prefunded Warrants and the Prefunded Warrant Shares to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in
United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U>, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, all exhibits and schedules thereto and hereto and any other documents or agreements
executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Computershare Trust Company, N.A., the current transfer agent of the Company, and any successor transfer agent
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Prefunded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the Common Warrant Shares and the Prefunded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE II.</B><BR>
PURCHASE AND SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.1 <U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
up to an aggregate of $5,000,006.40 of Shares and Common Warrants; <U>provided</U>, <U>howeve</U>r, that, to the extent that a Purchaser
determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s Affiliates, and any Person acting as a group
together with such purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially own in excess of the Beneficial Ownership
Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing Shares such Purchaser may elect to purchase Prefunded Warrants
in lieu of Shares in such manner to result in the same aggregate purchase price being paid by such Purchaser to the Company. The &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall be 4.99% (or, at the election of the Purchaser at Closing, 9.99%) of the number of shares of the
Common Stock outstanding immediately after giving effect to the issuance of the Securities on the Closing Date. Each Purchaser&rsquo;s
Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for &ldquo;Delivery Versus
Payment&rdquo; settlement with the Company or its designee. The Company shall deliver to each Purchaser its respective Shares and a Warrant
as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable
at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices
of EGS or such other location as the parties shall mutually agree take place remotely by electronic transfer of the Closing documentation.
Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;)
(i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo; names and addresses and released by
the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement
Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement
Agent (or its clearing firm) by wire transfer to the Company). Notwithstanding anything herein to the contrary, if at any time on or after
the time of execution of this Agreement by the Company and an applicable Purchaser, through, and including the time immediately prior
to the Closing (the &ldquo;<U>Pre-Settlement Period</U>&rdquo;), such Purchaser sells to any Person all, or any portion, of the Shares
to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement Shares</U>&rdquo;), such Purchaser
shall, automatically hereunder (without any additional required actions by such Purchaser or the Company), be deemed to be unconditionally
bound to purchase, such Pre-Settlement Shares to such Purchaser at the Closing; provided, that the Company shall not be required to deliver
any Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s receipt of the purchase price of such Pre-Settlement Shares hereunder;
and provided further that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant
by such Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall sell any shares of Common Stock to any Person
and that any such decision to sell any shares of Common Stock by such Purchaser shall solely be made at the time such Purchaser elects
to effect any such sale, if any. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise (as defined in the Prefunded
Warrants) delivered on or prior to 12:00 p.m. (New York City time) on the Closing Date, which may be delivered at any time after the time
of execution of this Agreement, the Company agrees to deliver the Prefunded Warrant Shares subject to such notice(s) by 4:00 p.m. (New
York City time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date (as defined in the Prefunded Warrants)
for purposes hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(a) On
or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) this
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) a
legal opinion of Company Counsel, substantially in the form of <U>Exhibit B</U> attached hereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) subject
to the fourth sentence of Section 2.1, the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company
letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv) subject
to the fourth sentence of Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to
deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) Shares
equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser
(minus the number of shares of Common Stock issuable upon exercise of such Purchaser&rsquo;s Prefunded Warrants, if applicable);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v) a
Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 125% of the sum
of such Purchaser&rsquo;s Shares and Prefunded Warrant Shares on the date hereof, with an exercise price equal to $3.23, subject to adjustment
therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi) for
each Purchaser of Prefunded Warrants pursuant to Section 2.1, a Prefunded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Prefunded Warrant
divided by the Per Share Purchase Price minus $0.001, with an exercise price equal to $0.001, subject to adjustment therein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii) the
Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(b) On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) this
Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) such
Purchaser&rsquo;s Subscription Amount, which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company
or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.3 <U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(a) The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) when
made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein
in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality,
in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(b) The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv) there
shall have been no Material Adverse Effect with respect to the Company since the date of this Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v) from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE III.</B><BR>
REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.1 <U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(a) <U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. Except as set forth on <U>Schedule
3.1(a)</U>, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear
of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid,
non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries,
all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(b) <U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization (to the extent such good standing concept
exists in such jurisdiction), with the requisite power and authority to own and use its properties and assets and to carry on its business
as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries
is duly qualified to conduct business and is in good standing (to the extent such good standing concept exists in such jurisdiction) as
a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes
such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would not have or reasonably
be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii)
a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company
and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect
on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;)
and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(c) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of the Company and
no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(d) <U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it
is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do
not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with
notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing
a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property
or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in
a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority
to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property
or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as would not
have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(e) <U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant
to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) application(s) to each applicable
Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby, (iv) the
filing of Form D with the Commission and applicable state securities regulators and (v) such filings as are required to be made under
applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(f) <U>Issuance
of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.
The Warrant Shares and Prefunded Warrant Shares, when issued in accordance with the terms of the Warrants and Prefunded Warrants, will
be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its
duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants and Prefunded
Warrants. The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which
became effective on&nbsp;April 11, 2022 (the &ldquo;<U>Effective Date</U>&rdquo;), including the Prospectus, and such amendments and supplements
thereto as may have been required to the date of this Agreement. The Registration Statement is effective under the Securities Act and
no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus
has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened
by the Commission. The Company, if required by the rules and regulations of the Commission, shall file the Prospectus Supplement with
the Commission pursuant to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective, at the date
of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material
respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and
any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing
Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an
untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading. The Company was at the time of the filing of the Registration Statement
eligible to use Form S-3. The Company is eligible to use Form S-3 under the Securities Act and it meets the transaction requirements with
respect to the aggregate market value of securities being sold pursuant to this offering and during the twelve (12) months prior to this
offering, as set forth in General Instruction I.B.6 of Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(g) <U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof.
Except as set forth on <U>Schedule 3.1(g)</U>, the Company has not issued any capital stock since its most recently filed periodic report
under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the
issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion
and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act.
No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities and as set forth on <U>Schedule
3.1(g)</U>, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right
to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock
Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary
to issue shares of Common Stock or other securities to any Person (other than the Purchasers). Except as set forth on <U>Schedule 3.1(g)</U>,
there are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion,
exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary (for purposes of
clarity, excluding only customary proportionate adjustments of the exercise, conversion, exchange or reset price in connection with a
subdivision of the outstanding shares of Common Stock into a larger number of shares or a combination of the outstanding shares of Common
Stock into a smaller number of shares). Except as set forth on <U>Schedule 3.1(g)</U>, there are no outstanding securities or instruments
of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.
Except as set forth on <U>Schedule 3.1(g)</U>, the Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo;
plans or agreements or any similar plan or agreement. To the Company&rsquo;s knowledge, all of the outstanding shares of capital stock
of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and
state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe
for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for
the issuance and sale of the Securities. Except as set forth on <U>Schedule 3.1(g)</U>, there are no stockholders agreements, voting agreements
or other similar agreements with respect to the voting of the Company&rsquo;s capital stock to which the Company is a party or, to the
knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(h) <U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two
years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus
Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension
of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates,
the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and
none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to
be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. The Company has not in the prior four years been an issuer described in Rule 144(i) under the Securities Act. The financial
statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the
rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared
in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(i) <U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has had or
that would reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or required to be disclosed
in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or
made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase
or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential
treatment of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)</U>,
no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist
with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial
condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made
or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(j) <U>Litigation</U>.
Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) would, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor, to the knowledge
of the Company, any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability
under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company,
there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer
of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement
filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(k) <U>Labor
Relations</U>. No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which would reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the
Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that
their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and
foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(l) <U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as would not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(m) <U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to
pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or
subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the
environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or
handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments,
licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder
(&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received all permits licenses or other approvals required of them under
applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of
any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply would be reasonably expected
to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(n) <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits would not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(o) <U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them, and good
and marketable title in all personal property owned by them, and valid leasehold rights to lease or otherwise use all real property and
all personal property leased by them, that is material to the business of the Company and the Subsidiaries, in each case free and clear
of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use
made and proposed to be made of such property by the Company and the Subsidiaries, (ii) Liens for the payment of federal, state or other
taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent
nor subject to penalties and (iii) Liens set forth on <U>Schedule 3.1(g)</U>. Any real property and facilities held under lease by the
Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries
are in compliance in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(p) <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have would have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the
rights of any Person, except as would not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable (other than patent and trademark applications) and there is no existing
infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security
measures to protect the secrecy, confidentiality and value of all of their Intellectual Property Rights, except where failure to do so
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(q) <U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary for companies of similar size as the Company in the businesses in which the Company and the Subsidiaries
are engaged, other than directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that
it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business without a significant increase in cost which would reasonably be expected to have
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(r) <U>Transactions
With Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of the Company or
any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any
transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(s) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. Except as set forth on <U>Schedule 3.1(s)</U>, the Company and the Subsidiaries are in compliance with
any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended that are effective as of the date hereof, and any and
all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing
Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that:
(i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access
to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed
by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time
periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness
of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently
filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most
recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure
controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in
the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have
materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its
Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(t) <U>Certain
Fees</U>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will
be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker,
bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section
that may be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(u) <U>Investment
Company</U>. The Company is not, and immediately after receipt of payment for the Securities will not be, an &ldquo;investment company&rdquo;
or a company that is &ldquo;controlled&rdquo; by an &ldquo;investment company&rdquo; as such terms are defined in the Investment Company
Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo;
subject to registration under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(v) <U>Registration
Rights</U>. Except as set forth on <U>Schedule 3.1(v)</U>, no Person has any right to cause the Company or any Subsidiary to effect the
registration under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(w) <U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
Except as set forth on <U>Schedule 3.1(w)</U>, the Company has not, in the 12 months preceding the date hereof, received notice from any
Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the
listing or maintenance requirements of such Trading Market. Except as set forth on <U>Schedule 3.1(w)</U>, the Company is, and has no
reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.
The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in
connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(x) <U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or would become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of
the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(y) <U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement.
The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities
of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and
correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated
by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser
makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically
set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(z) <U>No
Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither
the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales
of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be
integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of the Common
Warrants or Common Warrant Shares under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(aa) <U>Solvency</U>. Based
on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company of the
proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount that
will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known contingent liabilities)
as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as now conducted
and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted
by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the
Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated
uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid.
The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts
of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe
that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from
the Closing Date. <U>Schedule 3.1(aa)</U> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company
or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo;
means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary
course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or
not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by
endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the
present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither
the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(bb) <U>Tax Status</U>. Except
for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the
Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise
tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental
assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii)
has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to
which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority
of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(cc) <U>Foreign Corrupt Practices</U>.
Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf
of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other
unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which
is in violation of law, or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(dd) <U>Accountants</U>.
The Company&rsquo;s accounting firm is set forth on <U>Schedule 3.1(dd)</U> of the Disclosure Schedules. To the knowledge and belief of
the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its
opinion with respect to the financial statements to be included in the Company&rsquo;s next Annual Report. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(ee)  <U>Acknowledgment Regarding
Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely in the
capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company
further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with
respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective
representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental
to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s decision
to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(ff) <FONT STYLE="text-underline-style: double"><U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity. </U></FONT>Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(f) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been
asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges
that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding,
including, without limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities are being
determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests in the
Company at and after the time that the hedging activities are being conducted.&nbsp; The Company acknowledges that such aforementioned
hedging activities do not constitute a breach of any of the Transaction Documents.

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(gg) <U>Regulation M Compliance</U>.&nbsp;
The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause
or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any
of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii)
paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than,
in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(hh) [RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(ii) <U>Cybersecurity</U>.&nbsp;
(i)(x) To the Company&rsquo;s knowledge, there is no current or ongoing material security breach or other compromise of or relating to
any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including
the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment
or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified
of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise
to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and
all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and
contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data
from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material
Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain
and protect its material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and
Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with industry standards
and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(jj) <U>Stock Option Plans</U>.
To the Company&rsquo;s knowledge, each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i)
in accordance with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market
value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. To the Company&rsquo;s
knowledge, no stock option granted under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted,
and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate
the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries
or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(kk) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee or
affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control
of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(ll) <U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(mm) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended
(the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;).
Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the
outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is
subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises
a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal
Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(nn) <U>Money Laundering</U>.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes
and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Action or Proceeding
by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect
to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(oo) <U>Private
Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no registration
under the Securities Act is required for the offer and sale of the Common Warrants or the Common Warrant Shares by the Company to the
Purchasers as contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(pp) <U>No General Solicitation</U>.
Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Common Warrant or Common Warrant Shares
by any form of general solicitation or general advertising. The Company has offered the Common Warrants and Common Warrant Shares for
sale only to the Purchasers and certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(qq) <U>No Disqualification
Events</U>. With respect to the Common Warrants and Common Warrant Shares to be offered and sold hereunder in reliance on Rule 506 under
the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer
of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting
equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities
Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo;) is subject to
any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &ldquo;<U>Disqualification
Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care
to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable,
with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(rr) <U>Other Covered Persons</U>.
Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be
paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(ss) <U>Notice of Disqualification
Events</U>. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification Event relating to
any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become a Disqualification
Event relating to any Issuer Covered Person, in each case of which it is aware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.2 <U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(a) <U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(b) <U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.
Such Purchaser understands that the Common Warrants and the Common Warrant Shares are &ldquo;restricted securities&rdquo; and have not
been registered under the Securities Act or any applicable state securities law and is acquiring such Securities as principal for his,
her or its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the
Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of
the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons
to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law
(this representation and warranty not limiting such Purchaser&rsquo;s right to sell such Securities pursuant to a registration statement
or otherwise in compliance with applicable federal and state securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(c) <U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any Common Warrants, it will be an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7),
(a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(d) <U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(e) <U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment.&nbsp; Such Purchaser acknowledges and agrees that neither the
Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the
Securities nor is such information or advice necessary or desired.&nbsp; Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be provided to it.&nbsp; In connection with the issuance
of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary
to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(f) <U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that such Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by
the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons
party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners,
legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made
to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for
the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(g) <U>General
Solicitation</U>. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any
seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company acknowledges and
agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on
the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation
of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or
similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE IV.</B><BR>
OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.1 <U>Removal
of Legends</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(a) The
Warrants and Warrant Shares may only be disposed of in compliance with state and federal securities laws. In connection with any transfer
of Warrants or Warrant Shares other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate
of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide
to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which
opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred
Warrant under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Common Warrants or Common
Warrant Shares in the following form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES
INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF
ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED
INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Common Warrants or Common Warrant Shares to a financial institution that is an &ldquo;accredited
investor&rdquo; as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser
may transfer pledged or secured Common Warrants or Common Warrant Shares to the pledgees or secured parties. Such a pledge or transfer
would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be
required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the
Company will execute and deliver such reasonable documentation as a pledgee or secured party of Common Warrants and Common Warrant Shares
may reasonably request in connection with a pledge or transfer of the Common Warrants or Common Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(c) Certificates
evidencing the Common Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof): (i) while
a registration statement covering the resale of such security is effective under the Securities Act, or (ii) following any sale of such
Common Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Common Warrants), or (iii) if such Common Warrant Shares
are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants), or (iv) if such legend is not required under
applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission).
The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly if required by the Transfer
Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion of a Common Warrant
is exercised at a time when there is an effective registration statement to cover the resale of the Common Warrant Shares, or if such
Common Warrant Shares may be sold under Rule 144 (assuming cashless exercise of the Common Warrants) or if such legend is not otherwise
required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff
of the Commission) then such Common Warrant Shares shall be issued free of all legends. The Company agrees that following such time as
such legend is no longer required under this Section 4.1(c), the Company will, no later than the earlier of (i) two (2) Trading Days and
(ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to
the Company or the Transfer Agent of a certificate representing Common Warrant Shares, as applicable, issued with a restrictive legend
(such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate representing
such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions
to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Common Warrant Shares subject to legend removal
hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with
the Depository Trust Company System as directed by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means
the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the
Common Stock as in effect on the date of delivery of a certificate representing Common Warrant Shares issued with a restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(d) In
addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Common Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day
(increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend
Removal Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to
be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such
Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an
open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion
of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of
shares of Common Stock, that such Purchaser anticipated receiving from the Company without any restrictive legend, then an amount equal
to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any)
for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<B><U>Buy-In
Price</U></B>&rdquo;) over the product of (A) such number of Common Warrant Shares that the Company was required to deliver to such Purchaser
by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing
on the date of the delivery by such Purchaser to the Company of the applicable Common Warrant Shares (as the case may be) and ending on
the date of such delivery and payment under this Section 4.1(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(e) The
Shares, Prefunded Warrants, and Prefunded Warrant Shares shall be issued free of legends. If all or any portion of a Prefunded Warrant
is exercised at a time when there is an effective registration statement to cover the issuance or resale of the Prefunded Warrant Shares
or if the Prefunded Warrant is exercised via cashless exercise, the Prefunded Warrant Shares issued pursuant to any such exercise shall
be issued free of all legends. If at any time following the date hereof the Registration Statement (or any subsequent registration statement
registering the sale or resale of the Prefunded Warrant Shares) is not effective or is not otherwise available for the sale or resale
of the Prefunded Warrant Shares, the Company shall immediately notify the holders of the Prefunded Warrants in writing that such registration
statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and
available for the sale or resale of the Prefunded Warrant Shares (it being understood and agreed that the foregoing shall not limit the
ability of the Company to issue, or any Purchaser to sell, any of the Prefunded Warrant Shares in compliance with applicable federal and
state securities laws). The Company shall use commercially reasonable efforts to keep a registration statement (including the Registration
Statement) registering the issuance or resale of the Prefunded Warrant Shares effective during the term of the Prefunded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.2 <U>Furnishing
of Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(a) Until
the earlier of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants to timely file
(or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company
after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(b) At
any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Common
Warrant Shares (assuming cashless exercise) may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1)
and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current
public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes an issuer in
the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;Public Information Failure&rdquo;)
then, in addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated
damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Common Warrant Shares, an amount
in cash equal to one percent (1.0%) of the aggregate Exercise Price of such Purchaser&rsquo;s Common Warrants on the day of a Public Information
Failure and on every thirtieth (30<SUP>th</SUP>) day (pro rated for periods totaling less than thirty days) thereafter until the earlier
of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer required&nbsp; for
the Purchasers to transfer the Common Warrant Shares pursuant to Rule 144.&nbsp; The payments to which a Purchaser shall be entitled pursuant
to this Section 4.2(b) are referred to herein as &ldquo;Public Information Failure Payments.&rdquo;&nbsp; Public Information Failure Payments
shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure Payments are incurred
and (ii) the third (3<SUP>rd</SUP>) Business Day after the event or failure giving rise to the Public Information Failure Payments is
cured.&nbsp; In the event the Company fails to make Public Information Failure Payments in a timely manner, such Public Information Failure
Payments shall bear interest at the rate of 0.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit
such Purchaser&rsquo;s right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue
all remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.3 <U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require registration
under the Securities Act of the sale of the Common Warrants or Common Warrant Shares or that would be integrated with the offer or sale
of the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior
to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.4 <U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the
transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto,
with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents
to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the
Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without
limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition, effective
upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under
any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents,
employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers or any
of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms that
each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and each
Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and
neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior
consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect
to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required
by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) as required by federal securities law in connection with (i) filing any registration statement of the Company providing for the resale
by the Purchasers of the Common Warrant Shares issued and issuable upon exercise of the Common Warrants and (ii) the filing of final Transaction
Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the
Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with
such Purchaser regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.5 <U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.6 <U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes,
material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such information
and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each Purchaser
shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any
of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not
have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates
or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of their respective
officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade on the basis of,
such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice
provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any
Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant to a Current
Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions
in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.7 <U>Use
of Proceeds</U>. Except as set forth on <U>Schedule 4.7</U> attached hereto, the Company shall use the net proceeds from the sale of the
Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s
debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption
of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC
regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.8 <U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners
or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such
title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses,
liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court
costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of
or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions
contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations,
warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which
is finally judicially determined to constitute fraud, gross negligence or willful misconduct). If any action shall be brought against
any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify
the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably
acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate
in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent
that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable
period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a
material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable
to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written
consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage
or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements
made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8
shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received
or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser
Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.9 <U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares
pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.10 <U>Listing
of Common Stock</U>. The Company hereby agrees to use reasonable efforts to maintain the listing or quotation of the Common Stock on the
Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the
Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on such Trading
Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include
in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and
Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably
necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s
reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility
of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.11 [RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.12 <U>Subsequent
Equity Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(a) From
the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement
to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration
statement or amendment or supplement thereto, other than (A) the Prospectus Supplement, (B) filing a registration statement on Form S-8
in connection with any employee benefit plan, (C) filing a registration statement, or amendment to a registration statement, on Form S-4,
(D) filing a registration statement, or amendment to a registration statement with respect to the Common Warrant Shares, or (E) filing
a registration statement or amendment to a registration statement in connection with the Warrant Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(b) From
the date hereof until twelve (12) months after the Closing Date, the Company shall be prohibited from effecting or entering into an agreement
to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units
thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the Company
(i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to
receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based
upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such
debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after
the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related
to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;, whereby the Company may issue securities
at a future determined price; <U>provided</U>, <U>however</U>, that, after one hundred eighty (180) days after the Closing Date, the issuance
of shares of Common Stock in an &ldquo;at the market&rdquo; offering with H.C. Wainwright &amp; Co., LLC as sales agent shall not be deemed
a Variable Rate Transaction. Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance,
which remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(c) Notwithstanding
the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an
Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.13 <U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right
granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.14 <U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor
any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales
of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that
the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4.&nbsp; Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated
by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules
(other than as disclosed to its legal and other representatives).&nbsp; Notwithstanding the foregoing and notwithstanding anything contained
in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty
or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no
Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable
securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to
the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade
in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates,
or agent, including, without limitation, the Placement Agent, after the issuance of the initial press release as described in Section
4.4.&nbsp; Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio
managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment
decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above shall
only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities
covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.15 <U>Capital
Changes</U>. Until the one year anniversary of the Closing Date, the Company shall not undertake a reverse or forward stock split or reclassification
of the Common Stock without the prior written consent of the Purchasers holding a majority in interest of the Shares, other than a stock
split that, in the good faith determination of the Board of Directors, is required to enable the Company to comply with the required listing
standards for the Common Stock on the Company&rsquo;s principal Trading Market in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.16 <U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers
in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers
to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the
Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions
and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.17 <U>Form
D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Common Warrants and Common Warrant Shares as required
under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company
shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Common Warrants and Common Warrant Shares
for, sale to the Purchasers at the Closing under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States,
and shall provide evidence of such actions promptly upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE V.</B><BR>
MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.1 <U>Termination</U>.&nbsp;
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination
will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.2 <U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.3 <U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement,
contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.4 <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email
attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a
Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment
at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address
for such notices and communications shall be as set forth on the signature pages attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.5 <U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Prefunded Warrants
based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately
and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.6 <U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.7 <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other
than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or
transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by
the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.8 <U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company
in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of
the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be
enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.9 <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.10 <U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.11 <U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.13 <U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of
the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and
the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw,
in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part
without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission of an exercise
of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice
concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration
of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement
warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.14 <U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.15 <U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.16 <U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part
thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required
to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.17 <U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and
not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
EGS. EGS does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers
with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so
by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction
Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and
among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.18 <U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents
is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been
paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due
and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.19 <U>Saturdays, Sundays,
Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.20 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.21 <B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MAWSON INFRASTRUCTURE GROUP, INC.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for Notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="width: 31%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:</FONT></TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to (which shall not constitute notice):</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">MIGI</FONT>
SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory: _________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Securities to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prefunded Warrant Shares: ___________ Beneficial Ownership Blocker
 &#9744; 4.99% or &#9744;<FONT STYLE="font-family: Wingdings"></FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Warrant Shares: __________________ Beneficial Ownership
Blocker &#9744; <FONT STYLE="font-family: Wingdings"></FONT> 4.99% or &#9744;<FONT STYLE="font-family: Wingdings"></FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: ____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9744;<FONT STYLE="font-family: Wingdings"></FONT>
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company
to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing
shall occur on the second (2<SUP>nd</SUP>) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated
by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any
agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an
unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the
like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 36; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>ea178118ex99-1_mawson.htm
<DESCRIPTION>PRESS RELEASE, DATED MAY 4, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;<IMG SRC="ex99-1_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Mawson Infrastructure Group Inc. Announces $5
Million Registered Direct Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Sharon, Pennsylvania, USA &mdash; May 4, 2023
&mdash; </B>Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (&ldquo;Mawson&rdquo; or the &ldquo;Company&rdquo;), a digital infrastructure
provider, today announced a $5 million registered direct offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mawson has entered into a definitive agreement
with institutional investors for the issuance and sale of 2,083,336 shares of its common stock (or pre-funded warrants in lieu thereof)
at a purchase price of $2.40 per share of common stock (or $2.399 per pre-funded warrant, which represents the per share offering price
for the common stock less the $0.001 per share exercise price for each pre-funded warrant) in a registered direct offering. In addition,
in a concurrent private placement, the Company will issue to the institutional investors unregistered warrants to purchase up to 2,604,170
shares of its common stock with an exercise price of $3.23 per share and are exercisable six months following issuance for a period of
five and one-half years following issuance. The closing of the registered direct offering and the concurrent private placement is expected
to occur on or about May 8, 2023, subject to the satisfaction of customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">H.C. Wainwright &amp; Co. is acting as the
exclusive placement agent for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The gross proceeds to Mawson from the offering
are expected to be approximately $5 million, before deducting the placement agent&rsquo;s fees and other offering expenses payable by
Mawson. Mawson intends to use the net proceeds from this offering to continue to build out its digital infrastructure, for potential strategic
transactions and also for general corporate purposes, including working capital. <FONT STYLE="background-color: white">The shares of common
stock and pre-funded warrants described above are being offered and sold by Mawson pursuant to a &ldquo;shelf&rdquo; registration statement
on Form S-3 (File No. </FONT>333-264062<FONT STYLE="background-color: white">), including a base prospectus, previously filed with the
Securities and Exchange Commission, or the SEC, on April 1, 2022 and declared effective by the SEC on April 11, 2022. Such shares of common
stock and pre-funded warrants may be offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective
registration statement. A final prospectus supplement and an accompanying base prospectus relating to the registered direct offering will
be filed with the SEC. Electronic copies of the prospectus supplement and the accompanying base prospectus may be obtained, when available,
by visiting the SEC&rsquo;s website at&nbsp;http://www.sec.gov or by contacting </FONT>H.C. Wainwright &amp; Co., LLC at 430 Park Avenue,
3<SUP>rd</SUP> Floor, New York, NY 10022, by e-mail at placements@hcwco.com or telephone at (212) 856-5711.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants described above are being issued
in a concurrent private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;),
and Regulation D promulgated thereunder and, along with the shares of common stock underlying such warrants, have not been registered
under the Securities Act, or applicable state securities laws. Accordingly, the warrants and underlying shares of common stock may not
be offered or sold in the United States except pursuant to an effective registration statement or applicable exemption from the registration
requirements of the Securities Act and such applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also has agreed to amend certain existing
warrants to purchase up to 1,666,667 shares of the Company&rsquo;s common stock that were previously issued in July 2022 and have an exercise
price of $6.06 per share, effective upon the closing of the offering, such that the amended warrants will have a reduced exercise price
of $3.23 per share, will be exercisable six months following the closing of the offering, and will expire five and one-half years following
the closing of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">This press
release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall
there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such state or other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Mawson Infrastructure Group</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mawson Infrastructure Group (NASDAQ: MIGI) is
a digital infrastructure provider, with operations throughout the USA. Mawson&rsquo;s vertically integrated model is based on a long-term
strategy to promote the global transition to the new digital economy. Mawson matches sustainable energy infrastructure with next-generation
Mobile Data Center (MDC) solutions, enabling low-cost Bitcoin production and on-demand deployment of infrastructure assets. With a strong
focus on shareholder returns and an aligned board and management, Mawson Infrastructure Group is emerging as a global leader in ESG focused
Bitcoin mining and digital infrastructure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information, visit: www.mawsoninc.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Mawson cautions
that statements in this press release that are not a description of historical fact are forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words referencing
future events or circumstances such as &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo;
and &ldquo;will,&rdquo; among others. Because such statements are subject to risks and uncertainties, actual results may differ materially
from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon Mawson&rsquo;s current
expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events
could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which
include, without limitation, the possibility that Mawson&rsquo;s need and ability to raise additional capital, the satisfaction of the
closing conditions in this offering, the use of proceeds of this offering, the development and acceptance of digital asset networks and
digital assets and their protocols and software, the reduction in incentives to mine digital assets over time, the costs associated with
digital asset mining, the volatility in the value and prices of cryptocurrencies and further or new regulation of digital assets. More
detailed information about the risks and uncertainties affecting Mawson is contained under the heading &ldquo;Risk Factors&rdquo; included
in Mawson&rsquo;s Annual Report on Form 10-K filed with the SEC on March 23, 2023, and in other filings Mawson has made and may make with
the SEC in the future. One should not place undue reliance on these forward-looking statements, which speak only as of the date on which
they were made. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed
or implied by such forward-looking statements. Mawson undertakes no obligation to update such statements to reflect events that occur
or circumstances that exist after the date on which they were made, except as may be required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B><BR>
Brett Maas<BR>
646-536-7331<BR>
brett@haydenir.com<BR>
www.haydenir.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>migi-20230503.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /KpZw7xRiXgOn8uFa3VMOauD+bPty55z2ekxsGB/ffnaHyYnaju8LSsQ9jMW4fYL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:MIGI="http://mawsoninc.com/20230503" elementFormDefault="qualified" targetNamespace="http://mawsoninc.com/20230503">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://mawsoninc.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="migi-20230503_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="migi-20230503_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>migi-20230503_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>migi-20230503_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://mawsoninc.com/role/Cover" xlink:href="migi-20230503.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://mawsoninc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Q 6@# 2(  A$! Q$!_\0
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MQ3 ]##*>C _0]*>.E<-X(MSIL6H27.L6]X@P<QR%@G'O70+XHT9BB)J,#,V
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M %KA[&ZDLKJUNH0 \+*X!_E7IVH_%Z*\T&2WMK"9;N:,HS-]P<8)KIK.:<5
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MBO<E=YC9<G&.E<7'++97 FC)BFC;/R^QKZ#P/LOOY77\*^?;TC[5<_[[?SH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Q )H# 2(  A$! Q$!_\0
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MWBD:-HV=0Q1NJDCH?<5QNN^'M<M?&">*/#GV2:=[;[-=6EVQ59%!R&5AT(I
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MWHHH 0_UI#_6BB@!1TI:** "BBB@ J%_]8*** )J*** "BBB@ HHHH ****
#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139897292068928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 03, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  03,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Mawson Infrastructure Group Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001218683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0445167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">201 Clark Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Sharon<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">US<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">16146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+61 02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">8624 6130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value	<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MIGI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>ea178118-8k_mawson_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="migi-20230503.xsd" xlink:type="simple"/>
    <context id="From2023-05-03to2023-05-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001218683</identifier>
        </entity>
        <period>
            <startDate>2023-05-03</startDate>
            <endDate>2023-05-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-05-03to2023-05-03">0001218683</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-05-03to2023-05-03">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-05-03to2023-05-03">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-05-03to2023-05-03">2023-05-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-05-03to2023-05-03">Mawson Infrastructure Group Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-05-03to2023-05-03">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-05-03to2023-05-03">001-40849</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-05-03to2023-05-03">88-0445167</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-05-03to2023-05-03">201 Clark Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-05-03to2023-05-03">Sharon</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-05-03to2023-05-03">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="From2023-05-03to2023-05-03">US</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="From2023-05-03to2023-05-03">16146</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-05-03to2023-05-03">+61 02</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-05-03to2023-05-03">8624 6130</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-05-03to2023-05-03">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-05-03to2023-05-03">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-05-03to2023-05-03">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-05-03to2023-05-03">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-05-03to2023-05-03">Common Stock, $0.001 par value </dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-05-03to2023-05-03">MIGI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-05-03to2023-05-03">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-05-03to2023-05-03">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "K@*A6JL0B%C,!   B @  #P
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M2P$"% ,4    " "K@*A6RPWE?.\    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "K@*A6F5R<(Q &  "<)P
M$P              @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( *N J%8;1;:-8 0  ",1   8              " @0X(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "K@*A6GZ ;\+$"  #B#
M#0              @ &D#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( *N
MJ%:7BKL<P    !,"   +              "  8 /  !?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( *N J%:JQ"(6,P$  "("   /              "  6D0  !X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "K@*A6)!Z;HJT   #X 0  &@
M            @ ')$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " "K@*A699!YDAD!  #/ P  $P              @ &N$@  6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #X$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea178118-8k_mawson.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mawsoninc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea178118-8k_mawson.htm">ea178118-8k_mawson.htm</File>
    <File>ea178118ex10-1_mawson.htm</File>
    <File>ea178118ex4-1_mawson.htm</File>
    <File>ea178118ex4-2_mawson.htm</File>
    <File>ea178118ex4-3_mawson.htm</File>
    <File>ea178118ex4-4_mawson.htm</File>
    <File>ea178118ex5-1_mawson.htm</File>
    <File>ea178118ex99-1_mawson.htm</File>
    <File>migi-20230503.xsd</File>
    <File>migi-20230503_lab.xml</File>
    <File>migi-20230503_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea178118-8k_mawson.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea178118-8k_mawson.htm"
     ]
    },
    "labelLink": {
     "local": [
      "migi-20230503_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "migi-20230503_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "migi-20230503.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "MIGI",
   "nsuri": "http://mawsoninc.com/20230503",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea178118-8k_mawson.htm",
      "contextRef": "From2023-05-03to2023-05-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://mawsoninc.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea178118-8k_mawson.htm",
      "contextRef": "From2023-05-03to2023-05-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://mawsoninc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001213900-23-037335-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-037335-xbrl.zip
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MF]970YAAA?SSWN5)TCTL[I]T70]]W0EZKC_40]A#'*E9KM;*M59JD'+ C<Q
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M&J;BUG8A-:SL)N3P:CTSQ6)FS=#*RBX12^%$ZYGEXKP@^;@/RI@'H@<*V.V
M-"< P$@=;@](>@ZMOE56[%*Y"\P5V1R"A'B]$EA#S^9"*LBILH.+Z0(W\M5L
MT(WV?ELNF5GFS"4KZ:5>XX3M^&G\W#*QI6=QG]%2>*%:VN^\R^Y,_N5DNO7"
M^>1L'N#7-2>A -O #P_TD.\F2U C)6T3K\%63GE)M>3!R@"@'DJ49O$<.99
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M^T]MPLP4H,]CW70<$^T^SKIC9E"(<XBI^=& 4[E.-ORXO&0%#"@ K$8<N<]
M!([" =J/'L8D]8"9O&<YHOY4!&^JS<DJ^51M?)VMXD(W=BB HSI;5+GJ8>4J
MAIN%$5KKEFMRK.6EU&!%%??QJ&B1)B^FQJT\LVVVV%FH:FAE]W#*1CS2JYKN
M1(F\KIKNF&;;%Y,5,WI]PS?V6\UP4;7XT_RG&8#-[3H]Y0X]$Q?W9K EYEYS
M3+Z\1%QN3>07!L#"W 9_!EC8<<F[B0).O6!>F<7 NRPL\GC$"5S<*)K,'N/L
M(POF1BIT8$G0XO-;*X#W0##HCH'!-]V@8@U*!N--(J;NFX%(8)C3?*OZJAZ?
MMTES?.7QQ!Z3QU/20;Q':OS'GRQ]6O?W%Q] 31TP+7024@=4?WF2])EPCS#O
M0/_O$49J8%BQ #+E)G$YPZ=*[Y56*]BL%AG%7G9O)T[0JI/1$P#X7/]6[G(0
M P"E1U"GIVP5S(A@/'3*]*8N>#_!;USDN<)[#B4SF*X3\B'L4E7#&?'!(=:E
M8:[893I3Z1!V@/:4125*[;[/*5Y720/Y,@FZ4 ;*AZ"-. Y:K5"2]=QAJ3-S
M)7;?":SEI54L,ZI5=T:\1+]I.TP^B8+X">H)^53: ZH%5))L$%/)YVN,_""R
M76D/4B;F1>2#Q@E2>\!6R0R5 TVVQX.2-L0+LZPP0DT&>VHYMSP(75^I/%2:
MJ$(19"M U6=P4*#@K.DVZ6QLD(M %0C:3N_#1'UY_+)6JF[62_5Z"[2IN$=F
M-;5Z<55$#(]4H2F<4,&6(7SY0/CRL1,?>_5XI0@.Q%83I,;.?SSX*JS"\WFY
MAX%B<WEII/MH5F0!PO#S$75@GV1[/ "X#;;%(P31YVZ/'NCIN*MI^9S,_!Y0
M'> M/7 2VF'GLET-7%I>0H2N6I:UQK#XS(&]]7$?/=^Z13QZ(#:3G4U@%:T7
MJE41$8Q6 OND+]PDVF1\K0"$4IH4\W!1M+@02Q*_$Q@"TO04M0%'P)^U4JO:
M*&D;529W'X9,[\Z,85F&. 2.)A<E.HEU%&R>:)@R-]$S1J4C#Y[Q.^X;8 PJ
M*BP8#3&[O"1)-(V!#!X3WE2(J3",4,1T =L*3(1D2] 3.^E!X!I8MF/FQH8=
M"-A?-? _J5^8&FAY*1EI$MKYAJUO;94PQFT,L"(*L,1QG3A+PE93 ;>Q:)5D
MS00KQM@4[Z (X1CTG(1S<<[NK]04&4-_:A;A.D-7RTL)80'*K.&0F[A7]EBA
M#ZFS!([/+2<?*HM3H%.)=MSI(>BI;H)WV/J0')T0EL?0H0'7QK9G$#?5OJ;>
M!^G6BVQ;T&Z.WF>!)%V6>J569_-A)4UI<J;E)1FY3<%$K-IB=.H=,-8#4995
M22/+QK)I#\0P.'2W7(7.L,UU>'F@VSV&A^6#5&F:&F$^4$'#7P\FJ#M!:F]2
M8$S@S@I8$'5O4%6@+C>1KDBX(Y.0DF.!9ULH5< ]Y3Y,H_XFQ6N! ZG[RTN&
M[EDAJ&SR>75#Y$<IS!48OM456S@_7"5\5_=@)@,Q75FTZ_GRN;,="/5K4@ !
M!+TKS"XB$[2[")D3YE0I8P/I0QF)@&>Q\O0PSB"J*I'>1+DE5J!+RDFL+MHR
MH!"EC$5:6RB=V4:?25+^;01S:!MDL-8$P?0BGW3F!%WD[:Q]:7;(*S3P:*&L
M&,7Z3XY,M+PD)MA2$TRJ_+P%J)5:K1;\NS%-#2/9%XN25J7:2IMW*25[> >V
M#.G O!528AQP9Y!;0HH=WS)L-Z "5H'OQ/X)(@,-"1"65#XK-T^-GA=XP)!F
M9$"'"6!!!9+$BZ$M"7'4S8JOP+I3 BP103,!+!)L,R6:H)4IX_TV7/UH]7H>
M&T>( B):E=)#5VY37G\RG[1GSQ1_>^F2\1IM/&@)R"TT.#<#)N6ADGL]WQUF
M2(V-N"\+TN^LH3!K_FHR4%ZVA==QB9@,2"7@J%"Q0>+IZ'V>.K/3XUPH+3JI
MC9Z)G 2X@CL!-'KZF#@LZY+&U@O!*(K=@W3DV.%ALJ3)-4!/S A8#KB;\'LW
MLFR (0KI A/3ZJ,"7EZR,O& $DDTS\6[>3%,@N'K$'PO(Z>IT3RW Y=ZPV*Y
M#WW507..4M4#^@U2IY/8R/6_X4^I^1?.S+\S=19H1-PYW0)4&S '@.6/$Q]'
M3S9!:FE+J*84\8!VXSY=Y(A1?DJ:Q%T\W<<WA'PVN(\382Z##YWXC#N0:7Q>
M(C^V%.%]E_;3O>4.J9ELIS]_@].7F$VQKF*'F]"&22 =VTRAM5>M->!%H2$Q
M*83F&[ AN3[*M)]B<J@,$30Z%LB!,5O=JJZ!'34.I*M-XR<3+"_A#&02JCC<
MK>Y;)':(9U/\C6PK/%X#EY.?$&V_56V-=/=L2\!-F2K*:0#=)BF.WQG<BRW_
M@),304&]*>A\XM1R\2[_.OJZ+HY[4?1CJ)L\D\_3,:#BXCU5880^&OA":=,Z
M$PDFZ<WPVGN6>D<$4JR Q .%0^=T@=4Q59(T=-P=)P8!XB@GEDSQJW*=K8K[
M/MP*J]?KY5JK46W5U@2QXJJ$I1['QSY4KBIIQP'ACE.4J4M$X/]ML&5M,->5
MZQ H<U@&*$?D6QK@>Z(!'-O8R9OR56&G%Z\HCHB]> -T<>JI@\>('$<DBY>7
MXJW)!F&5@,L&^H'#G3Z80D2&-@]#%?M\@Y>9?@(1,"*]Q/ZC#[T=&*12PN*@
M;)PXMJG:_=06+"\E9*TILDZS@R!F$B/9$6(![(+$\=$="606'@R5 &DB9\;-
MR""@YQ0DY)E3DGEON,+:E Y FT]0EM(;60BS*"7E /9A\5I00 _0P*1X]T:E
M^K>"(G%C<Z:OKZL(678?A0/\UV:S5*U6:=&QW1K;J3"V#8.BJ1?! SNQ:M&N
M++N]L@<:B@/OQZ]8:0)B$_1#(_C<&G9A\\328))$0\A1L)>8&8'*&L:$(3)&
M*3R!JS!Y  S \=I0%=[*82Z.;DS& *30TC3A^,_')W-D"&(0EI<$#'GG7RPK
M#VG6BP<]BH4=:)O;@B8"+,M%6R]0I#P1&Q.*-HD43(5D6FB4?X\P5N>F J1
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MBZ7=" 9F6<]VD';41@&&? #X=W@0#8SH:QN!M_;YKPH,6_RS1TB:9?%LD9V
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M!I:STCEZ%(H@].]9"^TY28;8'"MI<^9"(U/&]SCT['&VD.U3\DB>'FH8QS0
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M:V[/%O1_C1I9$3J"_M@"XZT?>=E^!X;_MD.]Y4*_:68^1>!DS7\9UY%Z:WG
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M<\*@VI9[?B*X#X&U(V/23G)X;:O9\;>.&RG<9T3U& 'H=Q4#;K2I/RU#&.W
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M:E<L#=38=%T,=D#KWI2"] IX<4XV.;]]*L\JYI8[3\_;.?&GDL.<^;8 ]_[
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M@^HWW[0VJT"]$/'>TFJU\:&/"$9$?JB!*WS&8$1@;,=5=P.-U?S^>*+$ES0
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MW8%4,#L!W,O3U2QSC@^_>XMX2/S25S_EK*Y6 /3G#4 PH;B%(22<0H=\[_/
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MCQNB?@^?@%Q5;4$8(51D X3IB#UY7!.D)CAQ+G,N.7,"@+.6VI*(\Z;M:W!
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MBJ?]J<$+C(\-B>?IZ6&*&^XZ2*12&TZ/]GO("\'=&U2_<YS]K.CWV*N%G-#
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M&4M"D2OWW;^LJ188K=WP!Y\J=6-"K>6R!,E2=:9'\>).#9%%V)L0#,4C"6%
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M'GZZ,1T]?)N7LX[U%@W:\V^_GCV2/AA/(97VPQHK_G-O@\]S:[Q'GALF,:F
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M^[N7A[N__@P_O#E]N__S_P)02P,$%     @ JX"H5M:LW.\G10  O&L! !@
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ML:-@"Y_[<Q;_:U$\=Q__<TD?#L)^#Q8!/SH\/#T_.C[Y]?7?P^#-$+?O$K8
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M8/P:DG+*4E&A[P&[ S5L4J>%E<E58;N__)JS'=XZ?XJM6B5*6FM?\*.6+=
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MAGD7&[3GI5@^II<(U^&<)D>U,:J%]3Y!.F#9[[O4C%52[BXMH]D+[E/5C%9
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M?U-PFR)0W71EMPG_3(5HO6 =Q07O<:MH.SJOE4.J#3,,/O$;,,$S;$OJS]H
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MYDMY@Q7H_83?O'5$S$8KHN(/(A9!-U%7L/_"7"/PF09;S5LCG.^_DQ(3?;F
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M1?,*+I7ZTR.Z"R\N-2UBKP(L_*36 1?ND;HOET=Z[O!'_6%P>(I3/_GKH\=
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M]TY?!J].7Q^-SO^IW9__F769V3N-"A73(X)V1@@<7CX+[KBM:__SX =\O&\
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MGET7>6)<R2MP?O?>G;N!@7>]\GNA@V]ZI9^/5D:S*,V"E3S@2V_AADR^CB!
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M:>-0F(Y=3&WR(5,Z"LC>'+@;"O )/)-,X-_P03[1>K.\ L/U*"ZU5TQRQ:S
M*;!%G'C#R:X5C\,!B88",SIE@<U2H&L[O6/[OA.[OUFOI674*&/,,FJ& [KL
ML8[,H-H8*[-L@NF9+:5V93HN-<WKIE4':J*\DR)9-(IQD8:*E0BHL^4!TR\G
M^Z",BIS$804V GH;.?R:>(8@SV<,TY_WVI(J/XDL,R#T?RVR1N)U_(LR0ZIM
M+3,9ESKRK&HL=2#;T\G:6#WU2&;>:ZYNC2EMH&-'46;V+\^>[D3)]FP[VD(J
M^'M5?X@.\Q8N "YEA-3]X[.=)]&\^P@M=C2*80!Q3>->O[DX_'\'."W\Q]]P
MNJZ/R-[3ZZI8S)#Q8U(A+@'$*OKZ[7T>#CH;39R(#(PU=M>;C^,TA*E/>@E$
MTMS53E, 4;::3EO6$Q@"[=,I+Z+1E.&\/N&\Q=*<&/P*V<_;O/P0O9G#;X00
MMBA W>2S',V*JKY,2DG"XFS)RZR<8!K49)*)]Z6BFH?IHIRT*CF"1\'?\J1&
MO/VSJFG)*P]<U9"W$^7LS+RI])PI2+N5RME3!@WF49&,QG2G)I9,AKQ&1H*K
MX7(-$NWA0"KYUNPK#Z(>.<H\([:"9U<GP+*QAJ( ALNBZ;*J4AP'),IXR8&(
MMR8SFH:;);]5-1)MCB]$*6&XB"5MZ%#L/"(\3 X7 \'H]!74A=R OZP5109^
M)?L(,VXP0Q'&X)NL8R)VE%VE6&T$A1$4Z'?X-F5$FN1 (^MPM:[T6)NI 4FY
MGMBO)C*&@Y! ^"HBPTI[^;S=_5R10=PGL-5?6F0,!R&9$7T%D0$SZ9<9T1<4
M&3"1/ID1?4F101K-"ID1_:Y%QN,' @WXQ%FLDPCT9)/S(SD_3S8Y/]\*A8M:
M%*6C"'2BUQFPIE)<&<&"MJ_@KWU [?&N<\CM8E"N^PHET;]#_Z6?,^5GRT]0
M2PRYG$P*ODG:Y,19JB?BRC'%IB^DQ&@XV+_,3$6')$C!0Y,ZPQQ?"9BC9PRS
MP,-172ED3S/.I->?CY."G&GJV^14PQ4=9>2HPG+0BQHVSOBUVJNZ6EQ>T?OD
M*7P]5IIAS5."16[1(7RE2G.0I,T2%)F9'9P^>K]_Z,2EC3)$FZBTS81]@AA:
M9]<PZ6#\/HHZZ"R#_1%':RDH6$J&,6:*L4=/,I\I/YY29N<H[%N]=>2=+HWR
MY[NR*TXO;I+"?T2G\L-QR,&@>G(PBORR><]A&%WG04\H%2>VJK88WJI*E4PU
M(ONU&<I@0I:,\5L.!U(#)GNISYDU'_6@JA0K$S\-P">46.N2_9[^RC(;^"T.
M#((3#'4=]JI )DUKW 93R>:FD,MLP^5X.E8L*4KT 9<Z-BU=X?YB1QV%75'J
M&1Y9<F#6K)-DC\**0LG/F(DJV839E @>@"E?3K(#O3JU>5I[M:)0TAMW2QL^
M*\$.(L4T.Y /V\PS;?(E%3:TI]:9:\TUQ2IW-G^(MPJT Y7D /-A J3"KG$&
M.\Y\]TJ(>2HU4CTW&[G=< #_F@O(@R)DZ^YVB_/B**_E.\AC*C=?P5NH-V3,
M54<I)K0BO<Z3)=$!YJ*M/!:[;$/NPT37(W48R0@O@@(U,;5^:]4 ,VN]OR)@
MXS[QMR94G7KBR(+A  RLHO'K+N"D=-&O(Q5#81X+PF,%"UE!S;%C<PEESI.E
M.S8E1N-!4*"\R/^UR!F+(4UFH(HV&CH"O0$@@<JD:)?,7K,$B.X/N_'.SDZ
MOUH+P+MHE0D;)TNKLVWZT]36SL !2_T/NSMDD]N,!'.6</_9X!\._O"D^XRJ
M/<NG[56 "]VRT2.S&]WO$A\*?WDXH$(HSJ3J/L=Q2).< V,(N<#O)J '-JY8
M<E4Z">/![NNZR\24?R>LFJGLV([*@BM^N7]^@=?^LDYFZ/XN$(PC:2*O_A5?
MWW3\ #(I/*KM:%]02+CV.;:8<>#^#0=\ 2UF+)%QG%2COM"8"SNGY[&T#;$9
MI PYZ>$ L3IL7]4 MC!+2&UT(U*D6EJ\MNN@:G \59I;KN2JX<)VMU2<?;?
M3BOX*1X._ F8VM6M9N3P!(M6W"J\W2?/X([V^B75K(.%>K$J<Y :3C.(C69A
M+HK*T>PD9'8A8&)'9!N*M9$1PER%BLFL$ES<">"(/W[Z,G5U<?BW6JYWY@2W
MV&8&JB:69;Q54]LG0%>K-7>4GZ3!:@$Z7JYB/S3=>_:F?9,F=)\-C6/JS(F
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M=LVJN-EMP4O_TBE=0[DH[;HA=VJA:1FL3UKN%I7#!Q(OU*[VQMW0;)+5A4_
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MQ=&5</!+:E;6<"DO(&=@=/ +C,!PG4T;^MXKK/Q!#,ZB:1("UA"?^*Q*&<
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M7IE%(Z%8.2*0-P:!*JI;HT G(0Y.X>=1M:"8H=VL42E C]PMQ9&- 7X6<Z=
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M1:JGA.5^WO[SDV:RNL\]7^^QG_[\);F*[JQFDKG#[N[HZ7UK?WY17KQG!KU
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MPB5F7P1'V(+IFW#S?2V?V]=AC:=[)P?_1,9\^O;BW='K_P]02P,$%     @
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M)!'E-(M6C(T/H!V2U)9FEAFEB1;!,Q*I(N$%/\K6B23*\++T.\90$ O(&E*
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M#02DDOME9"DP2Q,U@/5"TI8Z/]T S+9./0Q=4)P YN!3DDKOEY3%(Z%4W0_
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M+FAT;5!+ 0(4 Q0    ( *N J%8S.3_PQJ8  ,YD P 9              "
M 6<C  !E83$W.#$Q.&5X,3 M,5]M87=S;VXN:'1M4$L! A0#%     @ JX"H
M5M:LW.\G10  O&L! !@              ( !9,H  &5A,3<X,3$X97@T+3%?
M;6%W<V]N+FAT;5!+ 0(4 Q0    ( *N J%;E/A4?F3\  /]: 0 8
M      "  <$/ 0!E83$W.#$Q.&5X-"TR7VUA=W-O;BYH=&U02P$"% ,4
M" "K@*A6UJ2,RK=%  !5=@$ &               @ &03P$ 96$Q-S@Q,3AE
M>#0M,U]M87=S;VXN:'1M4$L! A0#%     @ JX"H5@D04W7W!P  0"0  !@
M             ( !?94! &5A,3<X,3$X97@T+31?;6%W<V]N+FAT;5!+ 0(4
M Q0    ( *N J%;[?ZPRL@T  /(X   8              "  :J= 0!E83$W
M.#$Q.&5X-2TQ7VUA=W-O;BYH=&U02P$"% ,4    " "K@*A6/7RPB1X.  "5
M,   &0              @ &2JP$ 96$Q-S@Q,3AE>#DY+3%?;6%W<V]N+FAT
M;5!+ 0(4 Q0    ( *N J%8PW+'*+ ,  *X+   1              "  >>Y
M 0!M:6=I+3(P,C,P-3 S+GAS9%!+ 0(4 Q0    ( *N J%8M&F%+_@H  ("&
M   5              "  4*] 0!M:6=I+3(P,C,P-3 S7VQA8BYX;6Q02P$"
M% ,4    " "K@*A6+&7HV5<'  #75P  %0              @ %SR $ ;6EG
H:2TR,#(S,#4P,U]P<F4N>&UL4$L%!@     +  L ]0(  /W/ 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
